← Eichor
Condition: Runx1 Familial Platelet Disorder Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Runx1 Familial Platelet Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Longitudinal Studies of Patient With FPDMM
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT03854318Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Partic
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06414889Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06090669
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.